|
陈婉珺.高甘油三酯血症性急性胰腺炎的诊治进展与思考[J].内科急危重症杂志,2026,32(1):1-6
|
| DOI：10.11768/nkjwzzzz20260101 |
| CN KeyWords: 高甘油三酯血症性急性胰腺炎（HTG-AP） 发病机制 降脂治疗 |
| EN KeyWords:Hypertriglyceridemia-associated acute pancreatitis Pathogenesis Lipid-lowering treatment |
| Fund Project: |
| Author:CHEN Wan-jun |
| View Counts: 1065 |
| PDF Download Counts: 848 |
| CN Abstract: |
| 摘要 随着生活方式改变，高甘油三酯血症性急性胰腺炎（HTG-AP）已成为急性胰腺炎的重要亚型。本文在HTG-AP发病、疾病进展、疾病复发机制和相关因素的基础上，讨论降脂治疗的策略，涵盖无创治疗（饮食控制、药物治疗）及有创治疗（血液净化）。早期规范诊疗对改善HTG-AP预后至关重要，未来随着对发病机制的深入研究及多学科合作，将有望提高HTG-AP的诊治水平，改善患者预后。 |
| EN Abstract: |
| Abstract With the improvement of living standards, hypertriglyceridemia-associated acute pancreatitis (HTG-AP) has become an important subtype of acute pancreatitis. Based on the pathogenesis and progression mechanisms, as well as recurrence pathogenesis of HTG-AP,this article discusses lipid-lowering treatment strategies including non-invasive approaches (dietary control, pharmacological therapy) and invasive treatments (blood purification). Early standardized diagnosis and treatment are crucial for improving the prognosis of HTG-AP. In the future, with in-depth research into the pathogenesis and multidisciplinary collaboration, it is expected that the diagnosis and treatment level of HTG-AP will be enhanced, leading to improved patient outcomes. |
|
Full Text